Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Express Scripts
Argus Health
US Army
Cerilliant
Queensland Health
Deloitte
Moodys
Fuji

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,759,565

« Back to Dashboard

Summary for Patent: 5,759,565
Title: Galenic compositions comprising calcitonin and their use
Abstract:Pharmaceutical compositions for nasal administration comprising i) a calcitonin, and ii) benzalkonium chloride, and/or iv) a surfactant, suitable for application to the nasal mucosa, in iii) a liquid diluent or carrier, suitable for application to the nasal mucosa. The compositions are suitably adapted for administration in the form of a nasal spray.
Inventor(s): Azria; Moise (Basel, CH), Cavanak; Thomas (Biel-Benken, CH)
Assignee: Novartis Corporation (Summit, NJ)
Application Number:07/815,457
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 5,759,565

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,759,565

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8228390Oct 05, 1982
United Kingdom8236928Dec 30, 1982
United Kingdom8320865Aug 03, 1983
United Kingdom8322528Aug 22, 1983

International Patents Family Members for US Patent 5,759,565

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Hungary T34121 ➤ Subscribe
Hong Kong 27389 ➤ Subscribe
Switzerland 657779 ➤ Subscribe
Cyprus 1466 ➤ Subscribe
Germany 3335086 ➤ Subscribe
Denmark 114290 ➤ Subscribe
Denmark 174540 ➤ Subscribe
Denmark 458183 ➤ Subscribe
Denmark 161800 ➤ Subscribe
France 2533826 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Citi
Queensland Health
Farmers Insurance
Teva
Cerilliant
Novartis
Julphar
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot